| 摘要 |
The invention relates to compounds of formula (I):
where A is selected from:
and R 1 , R 2 , R 3 , R 4 , R 5 , R 10a , R 10b , M, Z, r and s are as defined in the description, useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), for example glucose tolerance, Type II diabetes or obesity. The invention also provides pharmaceutical compositions comprising such compounds. |
